Zhejiang Jolly Pharmaceutical Co.,LTD (SZSE:300181) agreed to acquire 8% stake in Zhejiang Top Medicine Co.,Ltd. from Yu Yin for CNY 10.7 million on December 27, 2021. The transaction is approved by board of directors of Zhejiang Jolly Pharmaceutical Co.,LTD.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.91 CNY | +2.83% | -0.40% | +39.87% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+39.87% | 1.44B | |
+39.33% | 6.11B | |
-18.38% | 4.35B | |
-9.17% | 3.18B | |
+3.98% | 3.16B | |
-3.41% | 2.51B | |
+48.74% | 1.98B | |
-4.82% | 1.74B | |
-1.24% | 1.63B | |
-8.96% | 1.6B |
- Stock Market
- Equities
- 300181 Stock
- News Zhejiang Jolly Pharmaceutical Co.,LTD
- Zhejiang Jolly Pharmaceutical Co.,LTD agreed to acquire 8% stake in Zhejiang Top Medicine Co.,Ltd. from Yu Yin for CNY 10.7 million.